Compound ID | 689
Class: Antimicrobial peptide
| Agent Type: | Natural product; Indirect acting; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Binds and neutralizes lipopolysaccharide and endotoxin to prevent the host's acute inflammatory response; endotoxin inhibitor; endotoxin antagonist |
| Description: | An endotoxin antagonist; immunomodulator; Ackermann K, Kawata T, Christ A, et al. Role of liposaccharide binding protein (LBP) in liposaccharide binding and activation of murine macrophage cells; inhibition by E5531. 32nd-Intersci-Conf-Antimicrobial-Agents-Chemother 1992; 337. |
| Institute where first reported: | Eisai Co. Ltd, Japan |
| Year first mentioned: | 1992 |
| Highest development stage: | Phase 2 |
| Development status: | Inactive |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/6442269 |
| Citations: |
|